Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2022-10-01
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Antenatal Education on Fear of Birth, Depression, Anxiety, Childbirth Self-efficacy, and Mode of Delivery in Primiparous Pregnant Women
NCT04097782
The Effect of Couples' Participation in Childbirth Preparation Education on Pregnant Women's Perceived Spousal Support, Fear of Childbirth, and Self-Efficacy
NCT07123623
The Effect of the Training Program Provided to Primipara Pregnant Women Through the Motivational Interview Method on Their Fear of Childbirth, Childbirth Self-Efficacy and Delivery Mode
NCT04660981
The Effect of Antenatal Education on Fear of Birth, Physiological Ability to Give Birth and Traumatic Birth Perception
NCT06196151
The Effect of Mindfulness-Based Pregnancy Education Program on Stress, Birth Fear and Birth Self-Efficacy in Pregnants
NCT05507307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention
The women allocated in experimental group will be given antenatal education for 6 weeks
Education
education
control
The women allocated for the control group will receive prenatal care services routinely provided at the outpatient clinics of the same hospital
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education
education
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Childbirth at fullterm (born at 38-42 weeks)
* Nulliparous women
* Women between the ages of 18-35
* Singleton pregnancy in 20 and 36 weeks of gestation
* Having a healthy newborn
* No participation in another prenatal program
* Absence of any psychiatric illness or comorbidities
* No use medications for a diagnosed mental disorder
* Baby with normal birth weight and APGAR score of 8 and above
* Women who have not developed postpartum complications
* Women without complicated/high-risk pregnancies, who do not experience a perinatal death or stillbirth
* Speaks and understands Turkish
* Women with a total fear of childbirth score W-DEQ-A ≥60 will be included.
* Women who give birth through vaginal route
Exclusion Criteria
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leyla Kaya
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leyla Kaya, PhD
Role: PRINCIPAL_INVESTIGATOR
Zeynep Kamil Women and Children's Diseases Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saglık Bilimleri Universitesi
Istanbul, , Turkey (Türkiye)
Zeynep Kamil Women's and Children's Diseases Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Kartal Dr.Lütfi Kırdar City Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08.06.2022-73
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.